Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial (Q34357213)

1 August 2017

title

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial (English)

1 reference

1 August 2017

0 references

0 references

0 references

1

Sandra D Comer

1 reference

1 August 2017

Maria A Sullivan

2

1 reference

1 August 2017

Elmer Yu

3

1 reference

1 August 2017

Jami L Rothenberg

4

1 reference

1 August 2017

Herbert D Kleber

5

1 reference

1 August 2017

Kyle Kampman

6

1 reference

1 August 2017

Charles Dackis

7

1 reference

1 August 2017

Charles P O'Brien

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

1 August 2017

1 reference

1 August 2017

volume

63

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

210-218

1 reference

Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Depot naltrexone: long-lasting antagonism of the effects of heroin in humans

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Worst-rank score analysis with informatively missing observations in clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

A sustained release depot for narcotic antagonists.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Clinical evaluation of a naltrexone sustained-release preparation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Implantable narcotic antagonists: a possible new treatment for narcotic addiction

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Retention and outcome in a narcotic antagonist treatment program.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Modification of the response to opioid and monopioid drugs by chronic opioid antagonist treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Naltrexone: lack of effect on hepatic enzymes.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effects of morphine.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Increased sensitivity to rate-altering and discriminative stimulus effects of morphine following continuous exposure to naltrexone.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Increased analgesic potency of mu agonists after continuous naloxone infusion in rats

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

A controlled trial of buprenorphine treatment for opioid dependence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Predicting Cocaine Use Among Methadone Patients: Analysis of Findings From a National Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Comparison of buprenorphine and methadone in the treatment of opioid dependence

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Lack of hepatotoxicity with naltrexone treatment

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

The treatment of heroin addiction: naltrexone alone and with behavior therapy.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the rat.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

High-Dose Naltrexone and Liver Function Safety

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4200530

Biocompatible implants for the sustained zero-order release of narcotic antagonists

9 December 2018

1 reference

12 December 2020

Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal Volunteers

1 reference

12 December 2020

A controlled trial of naltrexone in obese humans

1 reference

12 December 2020

Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration

1 reference

12 December 2020

Strategies to Improve Compliance with Narcotic Antagonists

1 reference

12 December 2020

Do methadone patients substitute other drugs for heroin? Predicting substance use at 1-year follow-up

1 reference

12 December 2020

10.1001/ARCHPSYC.63.2.210

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference